The FDA wants its regulators to learn more about new medical technologies that they may soon regulate. It has expanded its Experiential Learning Program so regulators can understand, for example, the manufacturing of glucose monitors, insulin pumps, mass spectrometry and assay development. http://medcitynews.com/2015/04/fda-expands-internal-program-learn-companies-medical-device-manufacturing/